Resources Contact Us Home
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety

Image Number 13 for United States Patent #8119616.

The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.

  Recently Added Patents
3D IC method and device
Method and apparatus for eliminating a motor vehicle tip-over risk
Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field
System and method for efficient resource management of a signal flow programmed digital signal processor code
Soybean cultivar CL1013675
Pre-distortion architecture for compensating non-linear effects
  Randomly Featured Patents
Method of making a glass panel assembly
Miniaturized microparticles
Hydrocarbon cracking
System for the forced waving of flags for advertising devices and similar and corresponding operation methods
Plasma display device and driving method of plasma display panel
Method of making compound semiconductor photodetector
Fluid control apparatus and method utilizing cellular array containing mini-vortex flow patterns
Multifunction cutting tool
Method and apparatus for guiding and transferring a sheet in a printing machine
Hydraulic elevator with dynamically programmed motor-operated valve